Indocyanine green fluorescence imaging system for sentinel lymph node biopsies in early breast cancer patients

Surg Today. 2011 Feb;41(2):197-202. doi: 10.1007/s00595-009-4254-8. Epub 2011 Jan 26.

Abstract

Purpose: This study presents a new method that enables the detection of sentinel lymph nodes (SLN) with high sensitivity using indocyanine green (ICG) fluorescence imaging.

Methods: This study enrolled 128 patients with clinically node-negative breast cancer. Fluorescence imaging was obtained after ICG was injected into the areola. Subcutaneous lymphatic channels were immediately visible.

Results: Lymphatic channels and SLN were successfully visualized in all patients. One lymphatic channel was 60%, two channels were 24%, and three channels were 16%. The number of fluorescence SLN ranged from 1 to 6, and blue-dyed SLN ranged from 0 to 3. In the latter, SLN were not identified in 44 patients. Nineteen patients had pathologically identified lymph node metastases. All of them were recognized by fluorescence imaging, but 8 patients had lymph nodes with metastases were not identified by dye method.

Conclusion: This ICG fluorescence imaging technique is feasible and safe for detecting SLN in a less invasive manner than conventional mapping, with real-time observations.

MeSH terms

  • Adult
  • Aged
  • Breast Neoplasms / pathology*
  • Female
  • Fluorescence
  • Humans
  • Indocyanine Green*
  • Middle Aged
  • Sensitivity and Specificity
  • Sentinel Lymph Node Biopsy / methods*

Substances

  • Indocyanine Green